医学
恶性胸腔积液
胸膜疾病
胸腔积液
胸膜液
重症监护医学
外科
放射科
肺
呼吸道疾病
内科学
作者
Michael A. Mitchell,Emilie Deschner,Inderdeep Dhaliwal,Michael Robinson,Li Pen,Chanel Kwok,Lorraine Cake,Emily Dawson,James Veenstra,Daniel Stollery,Ashley‐Mae Gillson,Kayvan Amjadi
出处
期刊:Thorax
[BMJ]
日期:2023-05-12
卷期号:78 (11): 1111-1117
被引量:6
标识
DOI:10.1136/thorax-2022-219449
摘要
Background Indwelling pleural catheters are an effective treatment option for patients with malignant pleural effusions. Despite their popularity, there remains a paucity of data on the patient experience and key patient-centred outcomes. Objective To investigate the experience of patients receiving an indwelling pleural catheter to better inform and identify potential areas for improvement in care. Methods This was a multicentre survey study at three academic, tertiary-care centres in Canada. Patients with a diagnosis of malignant pleural effusion who had an indwelling pleural catheter inserted were included. An adapted questionnaire specific to indwelling pleural catheters was used with responses recorded on a 4-point Likert scale. Patients completed the questionnaire in-person or by phone at 2-week and 3-month follow-up appointments. Results A total of 105 patients were enrolled in the study with 84 patients included in the final analysis. At the 2-week follow-up, patient-reported improvements in dyspnoea and quality of life from indwelling pleural catheter were high at 93% and 87%, respectively. The predominant issues identified were discomfort at time of insertion (58%), itching (49%), difficulty with sleeping (39%), discomfort with home drainage (36%) and the pleural catheter reminding patients of their disease (63%). Avoiding hospitalisation for the management of dyspnoea was important to 95% of patients. Findings were similar at 3 months. Conclusions Indwelling pleural catheters are an effective intervention to directly improve dyspnoea and quality of life but have important disadvantages for some; clinicians and patients should be aware of these when making an informed decision regarding treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI